Cargando…
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
BACKGROUND: Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to the challenges in recognizing immune-related adverse even...
Autores principales: | Ranjan, Surabhi, Quezado, Martha, Garren, Nancy, Boris, Lisa, Siegel, Christine, Lopes Abath Neto, Osorio, Theeler, Brett J., Park, Deric M., Nduom, Edjah, Zaghloul, Kareem A., Gilbert, Mark R., Wu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831705/ https://www.ncbi.nlm.nih.gov/pubmed/29490632 http://dx.doi.org/10.1186/s12885-018-4131-1 |
Ejemplares similares
-
Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section
por: Lynes, John, et al.
Publicado: (2020) -
CLRM-05 FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS
por: Dalmage, Mahalia, et al.
Publicado: (2022) -
Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
por: Yu, Guangyang, et al.
Publicado: (2021) -
Why would a black man volunteer for a government-funded science experiment?
por: Nduom, Edjah K.
Publicado: (2021) -
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch
por: Aboud, Orwa, et al.
Publicado: (2022)